Tesarakt
AI for a truly intelligent health system
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- tesarakt.com
- Total Funding
- $250K
- Last Round
- $250K SeedJul 2024
About
Tesarakt is a Columbia University spin-off developing predictive AI for neurological disease diagnosis. Using machine learning applied to conventional MRI scans and the largest available MRI database, the platform detects Parkinson's and Alzheimer's disease years before first symptoms appear. The company was founded in 2022 and participated in IndieBio NYC Class 4.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account